Trial: 202007146

An Open-label, Single-arm, Multicohort, Phase 2 Study to Assess the Efficacy and Safety of Tabelecleucel in Subjects with Epstein-Barr Virus-associated Diseases


II (Cancer Control)

Principal Investigator

Ghobadi, Armin

Disease Site

Hodgkin Lymphoma; Leukemia, other; Lymphoid Leukemia; Multiple Myeloma; Myeloid and Monocytic Leukemia; Non-Hodgkin Lymphoma; Other Hematopoietic

Learn more about this study at: